Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007095
Filing Date
2021-05-13
Accepted
2021-05-13 16:44:55
Documents
53
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aptx-20210331x10q.htm 10-Q 752477
2 EX-31.1 aptx-20210331ex3119f9d9b.htm EX-31.1 21873
3 EX-31.2 aptx-20210331ex3126bcbc8.htm EX-31.2 22050
4 EX-32.1 aptx-20210331ex32143005b.htm EX-32.1 10680
5 GRAPHIC aptx-20210331x10q001.jpg GRAPHIC 57871
  Complete submission text file 0001558370-21-007095.txt   4026059

Data Files

Seq Description Document Type Size
6 EX-101.INS aptx-20210331.xml EX-101.INS 929684
7 EX-101.SCH aptx-20210331.xsd EX-101.SCH 27575
8 EX-101.CAL aptx-20210331_cal.xml EX-101.CAL 33513
9 EX-101.DEF aptx-20210331_def.xml EX-101.DEF 93796
10 EX-101.LAB aptx-20210331_lab.xml EX-101.LAB 250299
11 EX-101.PRE aptx-20210331_pre.xml EX-101.PRE 203364
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

EIN.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38535 | Film No.: 21920316
SIC: 2834 Pharmaceutical Preparations